Perivan welcomes Genflow Biosciences Plc to our annual report portfolio
May 2025
Founded in 2020, Genflow Biosciences, listed on the Main Market of the London Stock Exchange, is a UK-based biotech firm with R&D facilities in Belgium focused on developing novel therapeutic approaches that potentially halt or slow the aging process supporting longer, healthier lives.
Publication of Annual Report
The Perivan shareholder communications team was delighted to be appointed to produce their latest Annual Report which was successfully published and posted to shareholders on 16th May 2025.
Perivan is the UK’s leading designer and producer of annual reports. For further information, click here.
